Trending Now

Certum Group Survey: 70% of In-House Counsel Know Litigation Funding, Only 6% Have Used It

Certum Group Survey: 70% of In-House Counsel Know Litigation Funding, Only 6% Have Used It

A new research brief from litigation finance and insurance provider Certum Group finds that corporate legal departments are broadly aware of litigation risk transfer products but almost never use them, a gap the firm describes as “the next frontier in corporate litigation strategy.”

According to the brief published by Certum Group, which surveyed 44 General Counsel and in-house litigation attorneys, roughly 70% of respondents are familiar with litigation funding but have never used it, while only about 6% have. The brief was authored by Kevin Skrzysowski, a Director at Certum Group, whose litigation funding team also includes Director William Marra, a former U.S. Supreme Court clerk.

The survey characterises in-house litigation risk as operational rather than existential. Employment and intellectual property disputes drew the highest concern levels, while roughly two-thirds of respondents reported no concern at all about antitrust or mass tort exposure. Decision-making was consistent across defensive and affirmative matters, with likelihood of success (~84%) and cost to pursue (~74%) the most frequently cited factors.

On affirmative claims, respondents said they would be more likely to proceed if cost and risk could be shifted to an insurer (~62%), a contingent-fee firm (~49%) or through claim monetisation (~46%). A litigation funder ranked lowest at ~28%. Looking forward, however, roughly 51% said they would consider litigation funding, ahead of capital protection insurance (~43%) and claim monetisation (~41%), with about 30% ruling out all such products.

Cost certainty (~51%) and budget constraints (~46%) were the leading drivers of interest. Among the small group that has used litigation funding, two-thirds reported satisfaction with the decision.

Commercial

View All

UPC Orders €200,000 Security After Finding Patent Claimant Had Pledged Its Assets to a Funder

The Unified Patent Court has ordered a newly formed patent claimant to post €200,000 in security for costs after concluding that the entity was economically assetless because its patents, licences and future income had all been pledged to its litigation funder.

As reported by Mishcon de Reya, the Hamburg Local Division reached that finding in *Nixu v Infoblox* (UPC_CFI_360/2026). Nixu, a US-domiciled claimant, was incorporated in March 2025 and acquired the patent in suit weeks later. The court declined to treat US domicile as a ground for security in itself, holding that "a claimant's domicile in the US did not, in itself, justify security for costs" and noting that US courts recognise European judgments.

What did justify security was the claimant's financial structure. Under a Patent Security Agreement, all patents, licences and future income were pledged to the funder, and part of the purchase price remained unpaid. The court found Nixu was "basically assetless in an economical sense" and dependent on discretionary support from its funder.

The same update reports a second security decision. In *La Siddhi v Athena Pharmaceutiques* (UPC_CoA_48/2026), the Court of Appeal upheld a €75,000 order against an SME claimant, confirming that "a party's SME status does not, by itself, exempt that party from the obligation to provide security for costs." The court distinguished fee reductions and cost ceilings available to SMEs from the security regime under Article 69(4) UPCA and Rule 158, which contains no SME carve-out. Security was set at roughly 60% of the applicable €112,000 recoverable costs ceiling.

Together the decisions suggest the UPC will look through corporate form to the funding arrangement itself when assessing whether a claimant can meet an adverse costs award.

Demotech Urges Insurers to Break Out Litigated Claims, Citing Funded Claim Generation

Insurance rating agency Demotech has called for a structural change to the way property and casualty insurers report loss costs, arguing that the current composite format masks the effect of technology-driven claim generation that is sometimes financed by third-party litigation funders.

As reported by PR Newswire, Joseph L. Petrelli, president and co-founder of Demotech, said the firm's 2022 review of failed carriers pointed to litigation as the decisive factor. "In 2022, our postmortem of failed carriers identified new, annual litigation as the proximate cause of what destroyed them," Petrelli said.

The argument turns on an assumption built into loss cost reporting decades ago. Petrelli noted that until the mid-1980s advisory organisations published rates and premiums for insurers to adopt or deviate from, and that "an implicit assumption underlying the original loss cost format was that an equilibrium existed in the relative claim frequency between claims reported and settled with policyholders, and claims litigated and negotiated with plaintiff firms."

Demotech's position is that the equilibrium no longer holds. Its research concluded that industrial-scale increases in litigated claims were achieved through technology, online marketing and advertising, "sometimes financed through third-party litigation funding." Petrelli also pointed to alternative business structures, managed services organisations and what he described as other mutations in the legal profession that "may circumvent the disclosure of third-party litigation funding."

The proposed remedy is to trifurcate loss cost data, disaggregating a single composite figure into claims closed without payment, litigated claims and non-litigated claims, each weighted by its own frequency. Demotech contends that the added granularity would allow insurers and regulators to price the litigated portion of a book directly rather than absorbing it into a blended average.

Nuclear Verdicts Climbed 40.7% in 2025 as Report Ties Growth to Eroding Tort Reform

A new annual study of large jury awards has recorded the steepest year of nuclear verdict activity since 2009, and it places the erosion of tort reform — including rules governing third-party litigation funding — among the forces driving the increase.

As reported by Insurance Journal, the latest edition of Marathon Strategies' *Corporate Verdicts Go Thermonuclear* report counted nearly 200 verdicts of $10 million or more against corporate defendants in 2025, a 40.7% rise over 2024 and the highest total in sixteen years. Those awards totalled $25.6 billion. Forty of them cleared $100 million, the threshold Marathon uses for a "thermonuclear" verdict, and four exceeded $1 billion.

The spread across the economy widened as well. The report identified nuclear verdicts in 68 industries, up from 55 the previous year and 48 the year before that. Product liability accounted for 29 verdicts worth roughly $12 billion, while the insurance sector recorded five verdicts totalling $390 million. Texas, California, Florida and Maryland saw the heaviest activity.

Marathon attributes the trend to a combination of factors, stating that its research "identified corporate mistrust, social pessimism, erosion of tort reform, and public desensitization to large numbers as among the most important."

The reference to tort reform is notable given the pace of state-level legislative activity. Eight states — Arkansas, Georgia, Kansas, Louisiana, Missouri, Montana, Oklahoma and South Carolina — enacted tort reform measures in 2025, and those packages included both damages caps and expanded disclosure obligations for third-party litigation funders.

The findings are likely to be cited on both sides of the funding debate, with defence-side advocates pointing to verdict growth as evidence that disclosure rules are needed, and funders noting that the report identifies broader social and economic drivers rather than isolating litigation finance as the cause.